Disrupting the production of a class of lipids known as sphingolipids in neurons improved symptoms of neurodegeneration and increased survival in a mouse model, according to new research led by the joint laboratory of Robert Farese, Jr. and Tobias Walther at Harvard T.H. Chan School of Public Health and Howard Hughes Medical Institute.
The findings, published online April 13, 2020 in the Proceedings of the National Academy of Sciences(PNAS), could help in the development of therapies for a range of neurodegenerative diseases.
